BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 20329783)

  • 1. Development of the Quantum-Inspired SIBFA Many-Body Polarizable Force Field: Enabling Condensed-Phase Molecular Dynamics Simulations.
    Naseem-Khan S; Lagardère L; Narth C; Cisneros GA; Ren P; Gresh N; Piquemal JP
    J Chem Theory Comput; 2022 Jun; 18(6):3607-3621. PubMed ID: 35575306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal Ion Modeling Using Classical Mechanics.
    Li P; Merz KM
    Chem Rev; 2017 Feb; 117(3):1564-1686. PubMed ID: 28045509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking as a popular tool in drug design, an in silico travel.
    de Ruyck J; Brysbaert G; Blossey R; Lensink MF
    Adv Appl Bioinform Chem; 2016; 9():1-11. PubMed ID: 27390530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The energy landscape of adenylate kinase during catalysis.
    Kerns SJ; Agafonov RV; Cho YJ; Pontiggia F; Otten R; Pachov DV; Kutter S; Phung LA; Murphy PN; Thai V; Alber T; Hagan MF; Kern D
    Nat Struct Mol Biol; 2015 Feb; 22(2):124-31. PubMed ID: 25580578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical electrostatics for biomolecular simulations.
    Cisneros GA; Karttunen M; Ren P; Sagui C
    Chem Rev; 2014 Jan; 114(1):779-814. PubMed ID: 23981057
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantum mechanical and molecular dynamics simulations of ureases and Zn beta-lactamases.
    Estiu G; Suárez D; Merz KM
    J Comput Chem; 2006 Sep; 27(12):1240-62. PubMed ID: 16773613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of 5-phospho-D-arabinonohydroxamate and 5-phospho-D-arabinonate inhibitors to zinc phosphomannose isomerase from Candida albicans studied by polarizable molecular mechanics and quantum mechanics.
    Roux C; Gresh N; Perera LE; Piquemal JP; Salmon L
    J Comput Chem; 2007 Apr; 28(5):938-57. PubMed ID: 17253648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Representation of Zn(II) complexes in polarizable molecular mechanics. Further refinements of the electrostatic and short-range contributions. Comparisons with parallel ab initio computations.
    Gresh N; Piquemal JP; Krauss M
    J Comput Chem; 2005 Aug; 26(11):1113-30. PubMed ID: 15934064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polarizable molecular mechanics studies of Cu(I)/Zn(II) superoxide dismutase: bimetallic binding site and structured waters.
    Gresh N; El Hage K; Perahia D; Piquemal JP; Berthomieu C; Berthomieu D
    J Comput Chem; 2014 Nov; 35(29):2096-106. PubMed ID: 25212748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexes of thiomandelate and captopril mercaptocarboxylate inhibitors to metallo-beta-lactamase by polarizable molecular mechanics. Validation on model binding sites by quantum chemistry.
    Antony J; Piquemal JP; Gresh N
    J Comput Chem; 2005 Aug; 26(11):1131-47. PubMed ID: 15937993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of D- and L-captopril inhibitors to metallo-beta-lactamase studied by polarizable molecular mechanics and quantum mechanics.
    Antony J; Gresh N; Olsen L; Hemmingsen L; Schofield CJ; Bauer R
    J Comput Chem; 2002 Oct; 23(13):1281-96. PubMed ID: 12210153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the interactions taking place in the recognition site of a bimetallic Mg(II)-Zn(II) enzyme, isopentenyl diphosphate isomerase. a parallel quantum-chemical and polarizable molecular mechanics study.
    Gresh N; Audiffren N; Piquemal JP; de Ruyck J; Ledecq M; Wouters J
    J Phys Chem B; 2010 Apr; 114(14):4884-95. PubMed ID: 20329783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, validation, and applications of anisotropic polarizable molecular mechanics to study ligand and drug-receptor interactions.
    Gresh N
    Curr Pharm Des; 2006; 12(17):2121-58. PubMed ID: 16796560
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.